Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease.
about
Minireview: nuclear receptor coregulators of the p160 family: insights into inflammation and metabolismPeroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal functionConjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma.The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice.Genetic ablation of steroid receptor coactivator-3 promotes PPAR-beta-mediated alternative activation of microglia in experimental autoimmune encephalomyelitis.Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunitySilencing Nogo-A promotes functional recovery in demyelinating disease.Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs.Effects of chronic systemic treatment with peroxisome proliferator-activated receptor α activators on neuroinflammation induced by intracerebral injection of lipopolysaccharide in adult mice.PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammationAutoantibodies associated with prenatal and childhood exposure to environmental chemicals in Faroese childrenReduced peroxisome proliferator-activated receptor α expression is associated with decreased survival and increased tissue bacterial load in sepsis.Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity.Gemfibrozil, a lipid lowering drug, inhibits the activation of primary human microglia via peroxisome proliferator-activated receptor β.The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases.PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis.PPAR agonists as therapeutics for CNS trauma and neurological diseasesIdentification and characterization of PPARα ligands in the hippocampus.Myelin alters the inflammatory phenotype of macrophages by activating PPARs.Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury.The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases.PPARα as a therapeutic target in inflammation-associated diseases.Sex-specific regulation of immune responses by PPARs.Alleviation of Toxicity Caused by Overactivation of Pparα through Pparα-Inducible miR-181a2.Sex Effects at the Ramparts: Nutrient- and Microbe-Mediated Regulation of the Immune-Metabolic Interface.Regulation of Oligodendrocyte Differentiation and Myelination by Nuclear Receptors: Role in Neurodegenerative Disorders.The Role of Lipid Metabolism in T Lymphocyte Differentiation and Survival.Metabolic Regulation of T Cell Immunity.Oleoylethanolamide treatment reduces neurobehavioral deficits and brain pathology in a mouse model of Gulf War Illness
P2860
Q28084780-BB3860FD-313B-4986-83D7-C7FADCF1EDDCQ28566540-3EEEA417-7A5A-4D50-A8C5-BAA6FBE2FE7CQ33652897-29D32A7B-14C6-4E5E-A85F-F78712E0639EQ33919749-29999844-8DF7-4857-9566-F4AAE354D145Q33992268-CD9DD813-D1D6-4CE1-9A70-5E7753D8B0C2Q34044412-46590BBC-0F3E-4BC9-A469-2ECCA66C869CQ34089956-AE56F511-A116-4F0B-BF1C-C1EA5CB37BA7Q34460512-DE23DDA7-8684-4DE3-9037-9DFE59ACF7E1Q34970533-74F85AE3-0E88-40A1-AD89-438B6022E124Q35053566-C233EE83-166F-49E9-AF0C-B551EA28BF0EQ35102612-FFE3FB9C-0639-4565-9402-CED2620781F0Q35680924-D91014F8-E822-45B2-AF63-630C466509FAQ35826774-0A98355B-24AD-423E-9719-7BFEDDB22DF5Q36074920-F31C940D-F6F8-446E-8EE0-7693F597AEFDQ36085086-C74DA1F3-EC5C-4108-AF66-098EC925EB9BQ36767657-935AFE70-2949-41AC-825E-CEEE7650F7AEQ37400355-FC077DC2-9FCC-4524-AF0F-1369728DE36EQ37415763-2FF47245-7728-47EC-9B53-58A8C7AEE841Q37484983-9FBE2EE1-60A6-48B7-BBF3-A250C3C57DE1Q37899155-15D0AECA-41C2-4C3B-ABEB-B6911FD940EFQ37989830-E2AEB6B9-BF64-4BBC-B3DE-AD07FD1CA5B8Q38038289-9E891D4A-B637-481D-B907-5173868E44ADQ40107299-67E03324-D4A8-43EC-A54F-6952A31A89DAQ47099331-596ADD07-EFCD-4FAF-838F-2904DB32A185Q47336618-74E77C46-ADAF-4905-9593-F1F8920C2E71Q48986828-1BA6BFF7-A8AA-486D-82FC-E1497757A49AQ49630753-E31088DB-165D-4A55-BABD-9D77086ECCDFQ50217787-3A1D1CB6-86BA-4CC7-AB93-23559D9B2A07Q58701360-7875F54E-714B-4F33-9268-F3CE932B5241
P2860
Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Transcriptional modulation of ...... gonists in autoimmune disease.
@ast
Transcriptional modulation of ...... gonists in autoimmune disease.
@en
Transcriptional modulation of ...... gonists in autoimmune disease.
@nl
type
label
Transcriptional modulation of ...... gonists in autoimmune disease.
@ast
Transcriptional modulation of ...... gonists in autoimmune disease.
@en
Transcriptional modulation of ...... gonists in autoimmune disease.
@nl
prefLabel
Transcriptional modulation of ...... gonists in autoimmune disease.
@ast
Transcriptional modulation of ...... gonists in autoimmune disease.
@en
Transcriptional modulation of ...... gonists in autoimmune disease.
@nl
P2093
P2860
P356
P1476
Transcriptional modulation of ...... gonists in autoimmune disease.
@en
P2093
Amy E Lovett-Racke
Anne R Gocke
Haiyan Peng
Jeffrey Weiner
Li-Hong Ben
Michael K Racke
Olaf Stuve
Paul D Drew
Rehana Z Hussain
Yuhong Yang
P2860
P304
P356
10.4049/JIMMUNOL.0713927
P407
P577
2009-04-01T00:00:00Z